Genetics and pathology of alpha-secretase site AβPP mutations in the understanding of Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 9, Issue SUPPL. 3, 2006, Pages 389-398

  Van Broeckhoven, Christine ^a,b   Kumar Singh, Samir ^a  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Alzheimer's disease; A PP mutations; Cerebral Amyloid Angiopathy (CAA); Cerebral hemorrhages; Dementia; Flemish APP692 disease; HCHWAD

Indexed keywords

ALPHA SECRETASE; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; PRESENILIN 1;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; BRAIN HEMORRHAGE; DEGENERATIVE DISEASE; DEMENTIA; DISEASE SEVERITY; GENE MUTATION; HUMAN; MOUSE; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW; TRANSGENIC MOUSE; VASCULAR AMYLOIDOSIS;

EID: 84880189563     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/jad-2006-9s344     Document Type: Review

References (101)

1. Alzheimer A. über eine eigenartige erkrankung der Hinrinde, Zentralblatt für Nervenheilkunde und Psychiatrie 18 (1907), 177-179.
2. E. Bakker, C. Van Broeckhoven, J. Haan et al., DNA diagnosis for hereditary cerebral hemorrhage with amyloidosis (Dutch type), Am J Hum Genet 49 (1991), 518-521.
3. D.R. Borchelt, G. Thinakaran, C.B. Eckman et al., Familial Alzheimer's disease-linked presenilin 1 variants elevate Abetal-42/1-40 ratio in vitro and in vivo, Neuron 17 (1996), 1005-1013.
4. M.E. Calhoun, P. Burgermeister, A.L. Phinney et al., Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid, Proc Natl Acad Sci USA 96 (1999), 14088-14093.
5. A. Clements, D. Allsop, D.M. Walsh and C.H. Williams, Aggregation and metal-binding properties of mutant forms of the amyloid A beta peptide of Alzheimer's disease, J Neurochem 66 (1996), 740-747.
6. A. Clements, D.M. Walsh, C.H. Williams and D. Allsop, Effects of the mutations Glu22 to Gln and Ala21 to Gly on the aggregation of a synthetic fragment of the Alzheimer's amyloid beta/A4 peptide, Neurosci Lett 161 (1993), 17-20.
7. P. Cras, F. van Harskamp, L. Hendriks et al., Presenile Alzheimer dementia characterized by amyloid angiopathy and large amyloid core type senile plaques in the APP 692Ala→Gly mutation, Acta Neuropathol 96 (1998), 253-260.
8. M. Cruts, H. Backhovens, S.Y. Wang et al., Molecular genetic analysis of familial early-onset Alzheimer's disease linked to chromosome 14q24.3, Hum Mol Genet 4 (1995), 2363-2371.
9. M. Cruts and C. Van Broeckhoven, Presenilin mutations in Alzheimer's disease, Human Mutation 11 (1998), 183-190.
10. J. Davis-Salinas and W.E. Van Nostrand, Amyloid beta-protein aggregation nullifies its pathologic properties in cultured cerebrovascular smooth muscle cells, J Biol Chem 270 (1995), 20887-20890.
11. C. De Jonghe, C. Zehr, D. Yager et al., Flemish and Dutch mutations in amyloid beta precursor protein have different effects on amyloid beta secretion, Neurobiol Dis 5 (1998), 281-286.
12. B. De Strooper, P. Saftig, K. Craessaerts et al., Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein, Nature 391 (1998), 387-390.
13. R. Deane, Y.S. Du, R.K. Submamaryan et al., RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain, Nat Med 9 (2003), 907-913.
14. R. Deane, Z.H. Wu, A. Sagare et al., LRP/amyloid beta-peptide interaction mediates differential brain efflux of A beta isoforms, Neuron 43 (2004), 333-344.
15. R.B. DeMattos, K.R. Bales, D.J. Cummins, S.M. Paul and D.M. Holtzman, Brain to plasma amyloid-beta efflux: a measure of brain amyloid burden in a mouse model of Alzheimer's disease, Science 295 (2002), 2264-2267.
16. B. Dermaut, S. Kumar-Singh, C. De Jonghe et al., Cerebral amyloid angiopathy is a pathogenic lesion in Alzheimer's disease due to a novel presenilin 1 mutation, Brain 124 (2001), 2383-2392.
17. P. Divry, Etude histochimique des plaques séniles, J Neurol Psychiat 27 (1934), 643-657.
18. J.E. Donahue, J.S. Khurana and L.S. Adelman, Intracerebral hemorrhage in two patients with Down's syndrome and cerebral amyloid angiopathy, Acta Neuropathol (Berl) 95 (1998), 213-216.
19. H. Fabian, G.I. Szendrei, H.H. Mantsch and L. Otvos Jr., Comparative analysis of human and Dutch-type Alzheimer beta-amyloid peptides by infrared spectroscopy and circular dichroism, Biochem Biophys Res Commun 191 (1993), 232-239.
20. M. Farzan, C.E. Schnitzler, N. Vasilieva, D. Leung and H. Choe, BACE2, a beta -secretase homolog, cleaves at the beta site and within the amyloid-beta region of the amyloid-beta precursor protein, Proc Natl Acad Sci USA 97 (2000), 9712-9717.
21. P.E. Fraser, J.T. Nguyen, H. Inouye et al., Fibril formation by primate, rodent and Dutch-hemorrhagic analogues of Alzheimer amyloid b-protein, Biochem 31 (1992), 10716-10723.
22. D. Games, D. Adams, R. Alessandrini et al., Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein, Nature 373(1995), 523-527.
23. G.G. Glenner and C.W. Wong, Alzheimer's disease and Down's syndrome: Sharing of a unique cerebrovascular amyloid fibril protein, Biochem Biophys Res Commun 122 (1984), 1131-1135.
24. G.G. Glenner and C.W. Wong, Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein, Biochem Biophys Res Commun 122 (1984), 885-890.
25. A. Goate, H.M. Chartier, M. Mullan et al., Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease, Nature 349 (1991), 704-706.
26. M. Goedert, C.M. Wischik, R.A. Crowther, J.E. Walker and A. Klug, Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau, Proc Natl Acad Sci USA 85 (1988), 4051-4055.
27. T.J. Grabowski, H.S. Cho, J.P. Vonsattel, G.W. Rebeck and S.M. Greenberg, Novel Amyloid Precursor Protein Mutation in an Iowa Family with Dementia and Severe Cerebral Amyloid Angiopathy, Ann Neurol 49 (2001), 697-705.
28. F. Gray, F. Dubas, E. Roullet and R. Escourolle, Leukoencephalopathy in diffuse hemorrhagic cerebral amyloid angiopathy, Ann Neurol 18 (1985), 54-59.
29. S.M. Greenberg, J.P. Vonsattel, J.W. Stakes, M. Gruber and S.P. Finklestein, The clinical spectrum of cerebral amyloid angiopathy: presentations without lobar hemorrhage, Neurology 43 (1993), 2073-2079.
30. I. Grundke-Iqbal, K. Iqbal, Y.C. Tung, M. Quinlan, H.M. Wisniewski and L.I. Binder, Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology, Proc Natl Acad Sci USA 83 (1986), 4913-4917.
31. I. Grundke-Iqbal, A.B. Johnson, H.M. Wisniewski, R.D. Terry and K. Iqbal, Evidence that Alzheimer neurofibrillary tangles originate from neurotubules, Lancet 1 (1979), 578-580.
32. J.F. Gusella, N.S. Wexler, P.M. Conneally et al., A polymorphic DNA marker genetically linked to Huntington's disease, Nature 306 (1983), 234-238.
33. J. Haan, J.A. Hardy and R.A.C. Roos, Hereditary cerebral hemorrhage with amyloidosis-Dutch type: its importance for Alzheimer research, 14 (TINS), 231-234.
34. C. Haass, A.Y. Hung, D.J. Selkoe and D.B. Teplow, Mutations associated with a locus for familial Alzheimer's disease result in alternative processing of amyloid beta-protein precursor, J Biol Chem 269 (1994), 17741-17748.
35. J. Hardy and D.J. Selkoe, The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics, Science 297 (2002), 353-356.
36. J.A. Hardy and G.A. Higgins, Alzheimer's disease: The amyloid cascade hypothesis, Science 256 (1992), 184-185.
37. D.M. Hartley, D.M. Walsh, C.P. Ye et al., Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons, J Neurosci 19 (1999), 8876-8884.
38. H. Hayashi, N. Kimura, H. Yamaguchi et al., A seed for Alzheimer amyloid in the brain, J Neurosci 24 (2004), 4894-4902.
39. L. Hendriks, C.M. van Duijn, P. Cras et al., Presenile dementia and cerebral haemorrhage linked to a mutation at condon 692 of the b-amyloid precursor protein gene, Nat Genet 1 (1992), 218-221.
40. M.C. Herzig, D.T. Winkler, P. Burgermeister et al., A beta is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis, Nature Neuroscience 7 (2004), 954-960.
41. L. Holcomb, M.N. Gordon, E. McGowan et al., Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes, Nat Med 4 (1998), 97-100.
42. D.S. Howland, M.J. Savage, F.A. Huntress et al., Mutant and native human beta-amyloid precursor proteins in transgenic mouse brain, Neurobiol Aging 16 (1995), 685-699.
43. K. Hsiao, P. Chapman, S. Nilsen et al., Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice, Science 274 (1996), 99-102.
44. M. Ikeda, V. Sharma, S.M. Sumi et al., The clinical phenotype of two missense mutations in the presenilin I gene in Japanese patients, Ann Neurol 40 (1996), 912-917.
45. J.T. Jarrett, E.P. Berger and P.T. Lansbury Jr., The carboxy terminus of the -amyloid protein is critical for the seeding of amyloid formation: Implications for the pathogenesis of Alzheimer's disease, Biochemistry 32 (1993), 4693-4697.
46. K. Kamino, H.T. Orr, H. Payami et al., Linkage and mutational analysis of familial Alzheimer disease kindreds for the APP gene region, Am J Hum Genet 51 (1992), 998-1014.
47. J. Kang, H-G. Lemaire, A. Unterbeck et al., The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor, Nature 325 (1987), 733-736.
48. K.S. Kosik, L.D. Orecchio, L. Binder, J.Q. Trojanowski, V.M. Lee and G. Lee, Epitopes that span the tau molecule are shared with paired helical filaments, Neuron 1 (1988), 817-825.
49. S. Kumar-Singh, P. Cras, R. Wang et al., Dense-core senile plaques in the Flemish variant of Alzheimer's disease are vasocentric, Am J Pathol 161 (2002), 507-520.
50. S. Kumar-Singh, C. De Jonghe, M. Cruts et al., Nonfibrillar diffuse amyloid deposition due to agamma(42)-secretase site mutation points to an essential role for N-truncated abeta(42) in Alzheimer's disease, Hum Mol Genet 9 (2000), 2589-2598.
51. S. Kumar-Singh, I. Dewachter, D. Moechars et al., Behavioral disturbances without amyloid deposits in mice overexpressing human amyloid precursor protein with Flemish (A692G) or Dutch (E693Q) mutation, Neurobiol Dis 7 (2000), 9-22.
52. S. Kumar-Singh, A. Julliams, D. Nuyens et al., In vitro studies of Flemish, Dutch, and wild type Amyloid β (Aβ) provide evidence for a two-stage Aβ neurotoxicity, Neurobiol Dis 11 (2002), 300-310.
53. S. Kumar-Singh, D. Pirici, E. McGowan et al., Dense core plaques in Tg2576 and PSAPP mouse models of Alzheimer's disease are centered on vessel walls, Am J Pathol 167 (2005), 527-543.
54. M.P. Lambert, A.K. Barlow, B.A. Chromy et al., Diffusible, nonfibrillar ligands derived from Abetal-42 are potent central nervous system neurotoxins, Proc Natl Acad Sci USA 95 (1998), 6448-6453.
55. E. Levy, M.D. Carman, I.J. Fernandez-Madrid et al., Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type, Science 248 (1990), 1124-1126.
56. M.L. Maat-Schieman, S.G. van Duinen, M. Bornebroek, J. Haan and R.A. Roos, Hereditary cerebral hemorrhage with amyloidosis-Dutch type (HCHWA-D): II-A review of histopathological aspects, Brain Pathol 6 (1996), 115-120.
57. D.M. Mann, T. Iwatsubo, N.J. Cairns et al., Amyloid beta protein (Abeta) deposition in chromosome 14-linked Alzheimer's disease: predominance of Abeta42(43), Ann Neurol 40 (1996), 149-156.
58. D.M. Mann, S.M. Pickering-Brown, A. Takeuchi and T. Iwatsubo, Amyloid Angiopathy and Variability in Amyloid beta Deposition Is Determined by Mutation Position in Presenilin-1-Linked Alzheimer's Disease, Am J Pathol 158 (2001), 2165-2175.
59. J.-J. Martin, J. Gheuens, M. Bruyland et al., Early-onset Alzheimer's disease in 2 large Belgian families, Neurology 41 (1991), 62-68.
60. C.L. Masters, G. Simms, N.A. Weinman, G. Multhaup, B.L. McDonals and K. Beyreuther, Amyloid plaque core protein in Alzheimer disease and Down syndrome, Proc Natl Acad Sci USA 82 (1985), 4245-4249.
61. Y. Matsuoka, M. Saito, J. LaFrancois et al., Novel therapeutic approach for the treatment of Alzheimer's disease by peripheral administration of agents with an affinity to beta-amyloid, J Neurosci 23 (2003), 29-33.
62. J.P. Melchor, L. McVoy and W.E. Van Nostrand, Charge alterations of E22 enhance the pathogenic properties of the amyloid beta-protein, J Neurochem 74 (2000), 2209-2212.
63. L. Miravalle, T. Tokuda, R. Chiarle et al., Substitutions at codon 22 of Alzheimer's A{beta} peptide induce conformational changes and diverse apoptotic effects in human cerebral endothelial cells, J Biol Chem 275 (2000), 27110-27116.
64. K. Murakami, K. Irie, A. Morimoto et al., Synthesis, aggregation, neurotoxicity, and secondary structure of various A beta 1-42 mutants of familial Alzheimer's disease at positions 21-23, Biochem Biophys Res Commun 294 (2002), 5-10.
65. R. Natte, M.L. Maat-Schieman, J. Haan, M. Bornebroek, R.A. Roos and S.G. van Duinen, Dementia in hereditary cerebral hemorrhage with amyloidosis-Dutch type is associated with cerebral amyloid angiopathy but is independent of plaques and neurofibrillary tangles, Ann Neurol 50 (2001), 765-772.
66. C. Nilsberth, A. Westlind_Danielsson, C. Eckman et al., The Arctic APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation, Nat Neurosci 4 (2001), 887-893.
67. D. Nochlin, T.D. Bird, E.J. Nemens, M.J. Ball and S.M. Sumi, Amyloid angiopathy in a Volga German family with Alzheimer's disease and a presenilin-2 mutation (N141I), Ann Neurol 43 (1998), 131-135.
68. G. Perry, N. Rizzuto, L. Autilio-Gambetti and P. Gambetti, Paired helical filaments from Alzheimer disease patients contain cytoskeletal components, Proc Natl Acad Sci USA 82 (1985), 3916-3920.
69. C.J. Pike, A.J. Walencewicz, C.G. Glabe and C.W. Cotman, Aggregation-related toxicity of synthetic beta-amyloid protein in hippocampal cultures, Eur J Pharmacol 207 (1991), 367-368.
70. G. Roks, F. van Harskamp, K.I. De et al., Presentation of amyloidosis in carriers of the codon 692 mutation in the amyloid precursor protein gene (APP692), Brain 123 (2000), 2130-2140.
71. D. Scheuner, C. Eckman, M. Jensen et al., Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease [see comments], Nat Med 2 (1996), 864-870.
72. W. Scholtz, Studien zur Pathologie der Hirngefässe. II. Die drüsige Entartung der Hirnarterien und -capillären, Z Gesamte Neurol Psychiat 162 (1938), 694-715.
73. R. Sherrington, E.I. Rogaev, Y. Liang et al., Cloning of a gene bearing mis-sense mutations in early-onset familial Alzheimer's disease, Nature 375 (1995), 754-760.
74. M. Shibata, S. Yamada, S.R. Kumar et al., Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier, J Clin Invest 106 (2000), 1489-1499.
75. A.K. Sian, E.R. Frears, O.M. El Agnaf et al., Oligomerization of beta-amyloid of the Alzheimer's and the Dutch-cerebral-haemorrhage types, Biochem J 349 (2000), 299-308.
76. A.B. Singleton, R. Hall, C.G. Ballard et al., Pathology of early-onset Alzheimer's disease cases bearing the Thr113-114ins presenilin-1 mutation, Brain 123(12) (2000), 2467-2474.
77. S. Sinha, J.P. Anderson, R. Barbour et al., Purification and cloning of amyloid precursor protein beta-secretase from human brain [see comments], Nature 402 (1999), 537-540.
78. S.S. Sisodia, E.H. Koo, K. Beyreuther, A. Unterbeck and D.L. Price, Evidence that b-amyloid protein in Alzheimer's disease is not derived by normal processing, Science 248 (1990), 492-495.
79. P. St George-Hyslop, J. Haines, E. Rogaev et al., Genetic evidence for a novel familial Alzheimer's disease locus on chromosome 14, Nature Genet 2 (1992), 330-334.
80. P. St George-Hyslop, R.E. Tanzi, P.J. Polinsky et al., The genetic defect causing familial Alzheimer's disease maps on chromosome 21, Science 235 (1987), 885-890.
81. C. Sturchler-Pierrat, D. Abramowski, M. Duke et al., Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology, Proc Natl Acad Sci USA 94 (1997), 13287-13292.
82. R.E. Tanzi, P. St George-Hyslop, J.L. Haines et al., The genetic defect in familial Alzheimer's disease is not tightly linked to the amyloid b-protein gene, Nature 329 (1987), 156-157.
83. L. van Bogaert, M. Maere and E. de Smedt, Sur les formes familiales précoces de la maladie d'Alzheimer, Mschr Psychiat Neurol 102 (1940), 249-301.
84. C. Van Broeckhoven, H. Backhovens, M. Cruts et al., Mapping of a gene predisposing to early-onset Alzheimer's disease to chromosome 14q24.3, Nat Genet 2 (1992), 335-339.
85. C. Van Broeckhoven, A.M. Genthe, A. Vandenberghe et al., Failure of familial Alzheimer's disease to segregate with the A4-amyloid gene in several European families, Nature 329 (1987), 153-155.
86. C. Van Broeckhoven, J. Haan, E. Bakker et al., Amyloid beta protein precursor gene and hereditary cerebral hemorrhage with amyloidosis (Dutch), Science 248 (1990), 1120-1122.
87. J. Van Dorpe, L. Smeijers, I. Dewachter et al., Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the london mutant of human APP in neurons [In Process Citation], Am J Pathol 157 (2000), 1283-1298.
88. S.G. van Duinen, E.M. Castaño, F. Prelli, G.T.A.B. Bots, W. Luyendijk and B. Frangione, Hereditary cerebral hemorrhage with amyloidosis in patients of Dutch origin is related to Alzheimer disease, Proc Natl Acad Sci USA 84 (1987), 5991-5994.
89. W.E. Van Nostrand, J. Davis-Salinas and S.M. Saporito-Irwin, Amyloid beta-protein induces the cerebrovascular cellular pathology of Alzheimer's disease and related disorders, Ann N Y Acad Sci 777 (1996), 297-302.
90. R. Vassar, B.D. Bennett, S. Babu-Khan et al., Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembraneasparticprotease BACE [see comments], Science 286 (1999), 735-741.
91. R. Vidal, M. Calero, P. Piccardo et al., Senile dementia associated with amyloid beta protein angiopathy and tau perivascular pathology but not neuritic plaques in patients homozygous for the APOE-epsilon4 allele, Acta Neuropathol (Berl) 100 (2000), 1-12.
92. D.M. Walsh, D.M. Hartley, M.M. Condron, D.J. Selkoe and D.B. Teplow, In vitro studies of amyloid beta-protein fibril assembly and toxicity provide clues to the aetiology of Flemish variant (Ala692→Gly) Alzheimer's disease, Biochem J 355 (2001), 869-877.
93. D.M. Walsh, I. Klyubin, J.V. Fadeeva et al., Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo, Nature 416 (2002), 535-539.
94. Z. Wang, R. Natte, J.A. Berliner, S.G. van Duinen, H.V. Vinters and W.I. Rosenblum, Toxicity of Dutch (E22Q) and Flemish (A21G) mutant amyloid beta proteins to human cerebral microvessel and aortic smooth muscle cells, Stroke 31 (2000), 534-538.
95. D.J. Watson, D.J. Selkoe and D.B. Teplow, Effects of the amyloid precursor protein Glu693→Gln Dutch mutation on the production and stability of amyloid beta-protein, Biochem J 340 (1999), 703-709.
96. R.O. Weller, A. Massey, T.A. Newman, M. Hutchings, Y.M. Kuo and A.E. Roher, Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease, Am J Pathol 153 (1998), 725-733.
97. K.E. Wisniewski, A.J. Dalton, D.R. Crapper-McLachlan, G.Y. Wen and H.M. Wisniewski, Alzheimer's disease in Down's syndrome: Clinicopathologic studies, Neurology 35 (1985), 957-961.
98. T. Wisniewski, J. Ghiso and B. Frangione, Peptides homologous to the amyloid protein of Alzheimer's disease containing a glutamine for glutamic acid substitution have accelerated amyloid fibril formation, Biochem Biophys Res Commun 179 (1991), 1247-1254.
99. M. Yasuda, K. Maeda, Y. Ikejiri, T. Kawamata, S. Kuroda and C. Tanaka, A novel missense mutation in the presenilin-1 gene in a familial Alzheimer's disease pedigree with abundant amyloid angiopathy, Neurosci Lett 232 (1997), 29-32.
100. S.H. Yen, F. Gaskin and R.D. Terry, Immunocytochemical studies of neurofibrillary tangles, Am J Pathol 104 (1981), 77-89.
101. B.V. Zlokovic, Clearing amyloid through the blood-brain barrier, J Neurochem 89 (2004), 807-811.